Stocks · Health care · Pharmaceutical Preparations

COLLEGIUM PHARMACEUTICAL, INC

COLL Clue Score59
United States Fiscal year ends December CIK 0001267565 Results filed 5 Nov 2026

What the insiders did No buying or selling

By person

16 insiders · 0 transactions

There is no salary here to measure against. COLLEGIUM PHARMACEUTICAL, INC's chief executive is paid a token, so dividing a holding by it says nothing.

Which is why this company is in neither direction of the chief executive filter on the transactions page. A stake that cannot be expressed as a multiple is not the same thing as a small one.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Rubric Capital Management LP entity
10% owner
—
—
—
3,132,743
$106.67M
−0.8%
Vikram Karnani
President and CEO
—
—
—
197,864
$6.74M
+52,523%
Colleen Tupper
EVP & Chief Financial Officer
—
—
—
147,282
$5.01M
+12.6%
Gino Santini
Director
—
—
—
112,483
$3.83M
+48.7%
Shirley R. Kuhlmann
EVP and General Counsel
—
—
—
108,137
$3.68M
−9.3%
John Gordon Freund
Director
—
—
—
107,081
$3.65M
+22.7%
Thomas B Smith
EVP and Chief Medical Officer
—
—
—
90,651
$3.09M
+63.8%
David Dieter
EVP & General Counsel
—
—
—
77,071
$2.62M
+733.7%
Scott Dreyer
EVP & Chief Commercial Officer
—
—
—
71,770
$2.44M
−32.2%
Garen G Bohlin
Director
—
—
—
71,000
$2.42M
+35.3%
John A. Fallon
Director
—
—
—
64,634
$2.20M
+17.9%
Rita J. Balice-Gordon
Director
—
—
—
61,370
$2.09M
+32.0%
Michael Thomas Heffernan
Director
—
—
—
50,328
$1.71M
+10.6%
Carlos Paya V
Director
—
—
—
28,323
$964.40K
—
Nancy Lurker
Director
—
—
—
26,758
$911.11K
—
Donovan Michael Glancy
Director
—
—
—
17,482
$595.26K
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.